About the Editors
Editor-in-Chief
Jing Liu, MD, PhD
Beijing An Zhen Hospital, Capital Medical University; Beijing Institute of Heart, Lung and Blood Vessel Diseases
Beijing, China
Dr. Jing Liu is Professor and Director of the Center for Clinical and Epidemiologic Research at Beijing AnZhen Hospital, Capital Medical University and Deputy Director of Beijing Institute of Heart, Lung, and Blood Vessel Diseases. Her research focuses on the epidemiology of cardiovascular disease. She has been the leader of the 30-year cohort study on cardiovascular disease - the Chinese Multi-provincial Cohort Study, and has played a key role in the WHO-Sino-MONICA project and the AHA-CSC collaborating project-Improving Care for Cardiovascular Disease in China. She serves as a key member in several writing committees of Chinese guidelines on the prevention and control of cardiovascular disease and authors on more than 200 scientific publications.
Associate Editors
Oleg Aslanidi, PhD
School of Biomedical Engineering & Imaging Sciences, King's College London
London, UK
Dr Oleg Aslanidi is a Professor in the School of Biomedical Engineering and Imaging Sciences at King's College London. His research is dedicated to improving cardiovascular health through advanced technology. His work focuses on understanding mechanisms of cardiovascular diseases and developing novel mechanism-driven tools for their efficient diagnosis and treatment. His expertise in patient imaging, image and data analysis, biophysical modelling and digital twinning, as well as artificial intelligence facilitates the development of such novel technologies for the cardiovascular system.
Julie McMullen, PhD
Baker Heart and Diabetes Institute
Melbourne, VIC, Australia
Professor Julie McMullen leads the Cardiac Hypertrophy Laboratory and Discovery & Preclinical Dept at the Baker Heart and Diabetes Institute. Her research interests include physiological and pathological heart enlargement (cardiac hypertrophy), exercise, heart failure, atrial fibrillation, cardiotoxicity, and improving research quality of preclinical studies. Prof McMullen is recognized internationally for research which defined the molecular distinction between physiological and pathological cardiac hypertrophy in mouse models of health and disease. She discovered that a signaling pathway activated with exercise (PI3K pathway) was critical for physiological hypertrophy (e.g. athlete’s heart) but not pathological hypertrophy (e.g. setting of hypertension). She has extensive experience in the generation and characterization of exercise trained mouse models, genetic and surgical mouse models of cardiac hypertrophy and failure, and has tested therapeutic approaches including adeno-associated virus (AAV) technology, RNA interference (i.e. LNA anti-miRNA oligonucleotides), small molecules, and lipid-based strategies. She has published in leading journals including PNAS, Circulation, Circ-Heart Failure, Nature Communications, Cell Reports, JACC and Nature Cardiovascular Research, and is a Fellow of the American Heart Association and International Society for Heart Research.
Xinliang (Xin) Ma, PhD
Thomas Jefferson University
Philadelphia, PA, USA
Xinliang (Xin) Ma received his MD degree in 1982 and Ph.D. degree in 1988. Following his postdoctoral training from 1989 to 2002 in the Department of Physiology at Thomas Jefferson University, he was recruited to the Department of Surgery as an Assistant Professor in 1993. He was promoted to Associate Professor in 1997 and Tenured Professor in 2002. He has published more than 270 original research papers, including more than 70 publications in those prestigious journals such as Nat Med, JCI, Circulation, JACC, EHJ, Cell Met, and Circ Res. His works have been cited by other investigators in the field more than 34,000 times, with an h-index of 80. He has been a member of the study section for NIH, AHA, and ADA. His research projects have been continually supported by NIH, ADA, and AHA since 1999. He is an editorial member of Circulation, Circulation Research, and the American Journal of Physiology. He is interested in identifying the signaling mechanisms responsible for ischemic myocardial injury with special emphasis on diabetic cardiovascular complications.
Minxian Wang, Principal Investigator
Beijing Institute of Genomics, Chinese Academy of Sciences and China National Center for Bioinformation
Beijing, China
Wallace is a principal investigator at the Beijing Institute of Genomics, Chinese Academy of Sciences, and China National Center for Bioinformation. He is particularly interested in using human genetics to advance our understanding of coronary artery disease, discover novel treatment targets, and develop innovative risk prediction tools for personalized care. He was a computational biologist at the Broad Institute of MIT and Harvard, working with Dr. Amit Khera and Dr. Sekar Kathiresan in human cardiovascular disease genetics and disease risk prediction. He completed a postdoctoral training supervised by Dr. Martin Pollak at the Harvard Medical School. He received his Ph.D. from the University of Chinese Academy of Sciences/CAS-MPG Partner Institute for Computational Biology, mentored by Dr. Yungang He, Dr. Shuhua Xu, and Dr. Felix Li Jin.
Yan Zhang, PhD
Peking University First Hospital
Beijing, China
Dr Yan Zhang is chief physician and professor in Department of Cardiology at Peking University First Hospital. He graduated from Peking University with medical doctoral degree (MD) and received postdoctoral research training in Harvard School of Public Health. His research interests are mainly focus on the epidemiology, genetic study and clinical research of cardiovascular disease.
Nathan Wong, PhD
University of California, Irvine
Irvine, California, USA
Dr. Nathan Wong is a cardiovascular epidemiologist, specialist in preventive cardiology, and Professor and Director, Heart Disease Prevention Program, Division of Cardiology at the University of California, Irvine, with joint appointments in epidemiology at UCLA and UC Irvine and population health and disease prevention at UC Irvine. He holds MPH and PhD degrees in epidemiology from Yale University and is a fellow of the American College of Cardiology, American Heart Association, National Lipid Association (NLA), and master of the American Society for Preventive Cardiology (ASPC). He is a past president of the ASPC, Pacific Lipid Association chapter of the NLA, and InterAmerican Heart Foundation serving Latin America. Dr. Wong’s primary research interests include subclinical atherosclerosis, where he did pioneering work with coronary calcium, as well as the epidemiology and management of dyslipidemia, diabetes, and obesity in relation to cardiovascular disease. He has been an investigator / collaborator with NIH studies including the Framingham Heart Study, Women’s Health Initiative, and Multiethnic Study of Atherosclerosis, and has conducted numerous clinical trials involving dyslipidemia. He has authored over 400 papers and co-edited seven textbooks, including the Braunwald Companion on Preventive Cardiology and two editions of the ASPC Manual of Preventive Cardiology. He is on the editorial board of several cardiology and diabetes-related journals, including co-editor-in-chief of the American Journal of Preventive Cardiology, and a guest editor-in-chief of JACC Asia and cardiovascular medicine section editor-in-chief of the Journal of Clinical Medicine. He is a recipient of the ASPC Joseph Stokes Award for lifetime achievement in preventive cardiology and lifetime achievement award in clinical research from the UC Irvine School of Medicine.
Clara Chow, PhD
Westmead Applied Research Centre, Faculty of Medicine and Health, University of Sydney
Sydney, NSW, Australia
Professor Clara Chow AM is Academic Director of the Westmead Applied Research Centre (WARC), Faculty of Medicine and Health, University of Sydney. She is a cardiologist and Clinical Lead of Community Based Cardiac Services at Westmead hospital and is also a member of the Western Sydney Local Health District (WSLHD) Governing Board, Sydney, Australia. Professor Chow is Director of the Australian Stroke and Heart Accelerator (ASHRA) and AAHMS Fellow (2023). She was honoured with a Telstra Brilliant Woman in Digital Health Award in 2022 and was the first female President of the Cardiac Society of Australia and New Zealand. Professor Chow’s research focuses on the prevention of cardiovascular disease, innovation in the delivery of cardiovascular care and the evaluation of digital health interventions.
Advisory Editors
Karina Huynh, PhD ORCiD
Melbourne, Australia.
Karina Huynh received her PhD from the BakerIDI Heart and Diabetes Institute in Melbourne, Australia, where she studied the role of antioxidant signalling in diabetic cardiomyopathy under the guidance of Dr Rebecca Ritchie and Dr Julie McMullen. She moved to London in 2013 and joined the Nature Reviews Cardiology team in 2014 as a locum Associate Editor. In mid-2015, she moved back to Australia, and is continuing her role as a Senior Editor of Nature Reviews Cardiology.
Faseeha Ayaz, PhD
London, UK
Faseeha joined Nature Communications in March 2023. She obtained her PhD in Cardiovascular Science from the University of Oxford where she worked on immunometabolism in the context of diabetes and vascular function. Prior to this, she studied pharmacology at Kings College London and worked in anti-doping. She primarily handles papers on cardiovascular biology and disease at Nature Communications.
Editorial Board Members
Abdelrahman Abushouk, MD,Yale School of Medicine, New Haven, Connecticut, USA
Nina Ajmone Marsan, MD, PhD, FESC, Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
Sanjeev Bhavnani, MD, Scripps Clinic, San Diego
Jeffrey Shi Kai Chan, MBChB, MPH, FESC, Observational and Pragmatic Research Institute, Singapore
Xiang Cheng, MD, PhD, The Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Pieterjan Dierickx, PhD, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany
Georgios V. Gkoutos, PhD, University of Birmingham, Birmingham, UK
Eduard Guasch, MD, PhD, Clinic Barcelona; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
Joseph P. Hart, MD, Medical College of Wisconsin, Milwaukee, WI, USA
Pengcheng He, MD, PhD, Department of Cardiology, Guangdong Provincial People's Hospital, Guangzhou, China
Haibo Jia, FACC, FESC, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China
Venkata Subbaiah Kadiam C, PhD, University of Rochester Medical Center, ROCHESTER, NY, USA
Nobuyuki Kagiyama, MD, PhD, Juntendo University Graduate School of Medicine, Tokyo, Japan
Rajesh G. Katare, MD, PhD, University of Otago, Dunedin, Otago, New Zealand
Chayakrit Krittanawong, MD, NYU Langone Health, New York, USA
Jian-Jun Li, MD, PhD, FESC, FACC, Fuwai Hospital, Chinese Academy of Medical Science, Beijing, China
Jing Liu, PhD, Peking University People’s Hospital, Beijing, China
Tong Liu, PhD, Department of Cardiology, Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Second Hospital of Tianjin Medical University, Tianjin, China
Mona Malek Mohammadi, PhD, Institute of Physiology I, Life & Brain Center, Medical Faculty University of Bonn, Bonn, Germany
Tu N. Nguyen, MD, PhD, University of Sydney, Sydney, NSW, Australia
Alessia Paldino, MD, PhD, Azienda sanitaria universitaria di trieste, Trieste, Italy
Aniruddh P. Patel, MD, Massachusetts General Hospital, Boston, MA
Giulio Francesco Romiti,MD, Sapienza - University of Rome,Rome, Italy
Francesco Santoro, MD, PhD, Department of medical and surgical sciences, University of Foggia, Foggia, Italy
Gary Tse, MD, PhD, Hong Kong Metropolitan University, Hong Kong, China
Ronald Vagnozzi, PhD, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Yajing Wang, MD, PhD, University of Alabama at Birmingham, Birmingham, AL, USA
Michelle Williams, MbChB PhD, University of Edinburgh, Scotland, United Kingdom
Junjie Xiao, PhD, Shanghai University, Shanghai, China
Sheng Xu, PhD, University of California San Diego, La Jolla
Junjie Zhang, MD, PhD, FSCAI, FESC, Nanjing First Hospital, Nanjing Medical University, Nanjing, China
Jie V. Zhao, PhD, The University of Hong Kong, Hong Kong, China
Lemin Zheng, PhD, Health Science Center, Peking University, Beijing, China.
